Safety of a Two-visit Cluster Schedule with Venom Immunotherapy
نویسندگان
چکیده
منابع مشابه
Prospective safety study of immunotherapy administered in a cluster schedule.
Cluster immunotherapy is becoming an alternative to conventional IT due to its shorter schedule, but the safety of such schedule is still controversial. At present, only few studies assess the risk of immunotherapy in a prospective manner, in well-controlled patients, using the same extract and intending to evaluate a single schedule. The aim of the present study is to evaluate the safety of a ...
متن کاملSafety and efficacy of venom immunotherapy: a real life study
INTRODUCTION Venom immunotherapy (VIT) is recommended as the first-line treatment for patients allergic to Hymenoptera venom. AIM To analyze the safety and efficacy of VIT in a real life setting. MATERIAL AND METHODS One hundred and eighty patients undergoing VIT were studied to evaluate the safety, efficacy, incidence and nature of symptoms after field stings and adverse reactions to VIT. ...
متن کاملSafety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
BACKGROUND The ultrarush protocol is an attractive approach in the buildup phase of venom immunotherapy (VIT-UR). However, the degree of risk of VIT-UR in children remains unknown. The objective of this study was to compare the safety of VIT-UR in children and adults. METHODS We performed a study based on prospectively gathered medical records of children and adults with hymenoptera venom all...
متن کاملVenom immunotherapy and pregnancy
Introductions The efficiency of venom immunotherapy (VIT) has been well documented by many studies. However, the most important for VIT is safety, particularly for a pregnant woman and a fetus. Aim To establish the influence of continuation of VIT on pregnant women and offspring. Material and methods The 6 women became pregnant during a specific immunotherapy. We retrospectively analyzed th...
متن کاملA 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy
Background Hymenoptera venom immunotherapy (VIT) is a clinically effective treatment. However, little is known about its long-term clinical efficacy and biological effects. Several mechanisms have been proposed to account for VIT efficacy, including reduction of specific IgE and induction of allergen-specific IgG4, but the overall picture remains elusive. We investigated Vespula VIT clinical ef...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Allergy and Clinical Immunology
سال: 2018
ISSN: 0091-6749
DOI: 10.1016/j.jaci.2017.12.775